Psyence Biomedical Ltd. (PBM) stock

PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30

$4.12−0.10 (-2.37%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Psyence Biomedical gross margin

Gross margin is gross profit as a percentage of revenue.

Psyence Biomedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?